CVMP adopts a draft strategy on antimicrobials 2021-2025
CVMP opinions on veterinary medicinal products
The Committee adopted by consensus a positive opinion for a grouped type II variation application for Bluevac BTV8 to add the strains BTV1 and BTV4 into the vaccine.
The Committee adopted by consensus a positive opinion for a type IB variation application for Stronghold Plus and Felisecto Plus (selamectin/sarolaner) to correct the translations of product information.
More information about the above-mentioned medicines, including their full indication, will be published on the Agency’s w
